Joint Corp (NASDAQ:JYNT) has earned an average broker rating score of 1.50 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating and one has assigned a strong buy rating to the company.
Brokerages have set a 1-year consensus price objective of $5.50 for the company and are anticipating that the company will post ($0.20) EPS for the current quarter, according to Zacks. Zacks has also given Joint Corp an industry rank of 68 out of 265 based on the ratings given to related companies.
A number of analysts recently commented on the stock. Zacks Investment Research upgraded shares of Joint Corp from a “hold” rating to a “buy” rating and set a $2.25 price objective for the company in a research report on Wednesday, August 17th. Maxim Group lowered their price objective on shares of Joint Corp from $8.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, July 1st. Finally, Feltl & Co. cut shares of Joint Corp from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 24th.
Shares of Joint Corp (NASDAQ:JYNT) traded up 0.58% during mid-day trading on Wednesday, hitting $2.44. The company’s stock had a trading volume of 14,200 shares. The company has a 50-day moving average price of $2.48 and a 200-day moving average price of $2.76. The stock’s market cap is $31.06 million. Joint Corp has a 1-year low of $1.85 and a 1-year high of $7.90.
Joint Corp (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, August 11th. The company reported ($0.26) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.27) by $0.01. The firm earned $5 million during the quarter, compared to the consensus estimate of $3.40 million. Analysts predict that Joint Corp will post ($0.97) EPS for the current fiscal year.
In other news, CEO Peter D. Holt bought 30,000 shares of the stock in a transaction on Monday, August 29th. The stock was purchased at an average price of $2.66 per share, for a total transaction of $79,800.00. Following the acquisition, the chief executive officer now owns 10,000 shares in the company, valued at $26,600. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
A number of institutional investors have recently added to or reduced their stakes in JYNT. Sanders Morris Harris Inc. boosted its position in Joint Corp by 7.0% in the second quarter. Sanders Morris Harris Inc. now owns 2,063,581 shares of the company’s stock worth $4,189,000 after buying an additional 134,753 shares during the period. Emerald Acquisition Ltd. purchased a new position in Joint Corp during the second quarter worth about $108,000. Skylands Capital LLC boosted its position in Joint Corp by 12.1% in the second quarter. Skylands Capital LLC now owns 380,734 shares of the company’s stock worth $773,000 after buying an additional 40,950 shares during the period. Finally, Boston Partners boosted its position in Joint Corp by 1.1% in the second quarter. Boston Partners now owns 108,550 shares of the company’s stock worth $220,000 after buying an additional 1,170 shares during the period.
About Joint Corp
The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Joint Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint Corp and related companies with MarketBeat.com's FREE daily email newsletter.